Featured Articles : HemaSphere

Journal Logo

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis

Hermans, Sjoerd J. F.; Versluis, Jurjen; Labopin, Myriam; More

HemaSphere. 7(3):e846, March 2023.

In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury

Federti, Enrica; Matte, Alessandro; Recchiuti, Antonio; More

HemaSphere. 7(3):e848, March 2023.

Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel

Pagano, Livio; Zinzani, Pier Luigi; Pileri, Stefano; More

HemaSphere. 7(3):e841, March 2023.

Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial

Weisel, Katja; Dimopoulos, Meletios A.; San-Miguel, Jesús; More

HemaSphere. 7(3):e843, March 2023.